doi: 10.1177/10781552231178686 15
Insurance coverage remains inconsistent, and supply chain disruptions can make access unpredictable
Berberine should not be described as a GLP-1 'activator' in the medicinal sense, as any effects on GLP-1 pathways appear to be indirect and considerably less potent than pharmaceutical GLP-1 therapies
How does semaglutide affect diabetes management
CrossRef Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis Xuzhen Yan, Qi Han, Yiwen Wang, Weiyu Li, Ning Zhang, Xu Fan, Wei Chen, Hong You, Aiting Yang Cellular and Molecular Gastroenterology and Hepatology .2026
Traditional Chinese medicine and natural products possess unique advantages in simultaneously intervention on multiple modes of RCD (131, 176, 177, 194, 202)